Development of Mouse‐Tumor Model Using Prostate Cancer (PC3) Cell Line for High‐Intensity Focused Ultrasound (HIFU) Ablation

Documenti analoghi

• The Impact of Tumor Microenvironmental Acidity on Bicalutamide Sensitivity in Prostate Cancer Cells
  di: Pedram Golmohammadi, et al.
  Pubblicazione: (2026)
• Metformin and Flutamide Combination Therapy’s Efficacy and Safety in Prostate Cancer Cell Lines
  di: AhmadReza Rezaeian, et al.
  Pubblicazione: (2026)
• In Vitro Effects of Cabazitaxel and Menadione on Cell Growth, Metabolism, and Transcriptomic Profile of Human Prostate Cancer Cell Lines
  di: Ana Laura Gómez-Rosas, et al.
  Pubblicazione: (2026)
• Evaluation of Second‐Line Treatment for Castration‐Resistant Prostate Cancer following the Administration of Upfront Androgen Receptor Signaling Inhibitors
  di: Kazuro Kikkawa, et al.
  Pubblicazione: (2024)
• MRI‐Determined Tumor Contact Area as a Predictor of Pathological Extraprostatic Extension in Clinical T2 Prostate Cancer
  di: Masashi Tsujimoto, et al.
  Pubblicazione: (2025)